These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20402249)

  • 21. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].
    Watanabe A
    Nihon Rinsho; 2003 Nov; 61(11):1987-91. PubMed ID: 14619443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
    Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
    Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 26. Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    Eisen DP; McBryde ES
    J Infect Dis; 2009 Nov; 200(10):1627-8. PubMed ID: 19857155
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
    Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
    Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001.
    Burwen DR; Ball R; Bryan WW; Izurieta HS; La Voie L; Gibbs NA; Kliman R; Braun MM
    Am J Prev Med; 2010 Oct; 39(4):296-304. PubMed ID: 20837279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barré syndrome associated with H1N1 vaccination.
    Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
    Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.
    Mayet A; Ligier C; Gache K; Manet G; Nivoix P; Dia A; Haus-Cheymol R; Verret C; Duron S; Faure N; Piarroux M; De Laval F; Simon F; Decam C; Chaudet H; Meynard JB; Rapp C; Deparis X; Migliani R
    Vaccine; 2011 Mar; 29(14):2576-81. PubMed ID: 21296693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
    Price LC
    BMJ; 2009 Sep; 339():b3577. PubMed ID: 19740925
    [No Abstract]   [Full Text] [Related]  

  • 33. [National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].
    Durrieu G; Caillet C; Lacroix I; Jacquet A; Faucher A; Ouaret S; Sommet A; Perault-Pochat MC; Kreft-Jaïs C; Castot A; Damase-Michel C; Montastruc JL;
    Therapie; 2011; 66(6):527-40. PubMed ID: 22186078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety and effectiveness of the influenza vaccine: new data, new challenges].
    Trilla A
    Med Clin (Barc); 2013 Jul; 141(2):67-9. PubMed ID: 23768850
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.
    Galeotti F; Massari M; D'Alessandro R; Beghi E; Chiò A; Logroscino G; Filippini G; Benedetti MD; Pugliatti M; Santuccio C; Raschetti R;
    Eur J Epidemiol; 2013 May; 28(5):433-44. PubMed ID: 23543123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pandemic influenza: a priority for the neurological community.
    Lancet Neurol; 2009 Oct; 8(10):869. PubMed ID: 19747645
    [No Abstract]   [Full Text] [Related]  

  • 40. Shoenfeld's syndrome after pandemic influenza A/H1N1 vaccination.
    Barros SM; Carvalho JF
    Acta Reumatol Port; 2011; 36(1):65-8. PubMed ID: 21483283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.